Azacitidine
| Azacitidine | |
|---|---|
| Term | Azacitidine |
| Short definition | Azacitidine (ay-zuh-SY-tih-deen) A drug used under the brand names Onureg to treat adults with certain types of acute myeloid leukemia and Vidaza to treat adults with certain types of myelodysplastic syndromes and children from 1 month of age with newly diagnosed juvenile myelomonocytic leukemia. It is also being studied in the treatment of other types of cancer. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Azacitidine - (pronounced) (ay-zuh-SY-tih-deen) A drug used under the brand names Onureg to treat adults with certain types of acute myeloid leukemia and Vidaza to treat adults with certain types of myelodysplastic syndromes and children from 1 month of age with newly diagnosed juvenile myelomonocytic leukemia. It is also being studied in the treatment of other types of cancer. Azacitidine stops cells from making DNA and can kill cancer cells. It's a type of antimetabolite
External links
- Medical encyclopedia article on Azacitidine
- Wikipedia's article - Azacitidine
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski